IMRX vs GILD: Which Stock is Better?
Side-by-side comparison of Immuneering Corp and Gilead Sciences Inc in 2026
IMRX
Immuneering Corp
$5.41
GILD
Gilead Sciences Inc
$139.77
Key Metrics Comparison
| Metric | IMRX | GILD | Winner |
|---|---|---|---|
| Market Cap | $368.52M | $174.33B | GILD |
| P/E Ratio | N/A | 20.72 | GILD |
| EPS (TTM) | $N/A | $6.78 | GILD |
| Revenue Growth | -1.0% | 0.0% | GILD |
| Gross Margin | 34907.7% | 78.8% | IMRX |
Analyze IMRX
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IMRX or GILD a better investment?
Comparing IMRX and GILD: Immuneering Corp has a market cap of $368.52M while Gilead Sciences Inc has $174.33B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IMRX and GILD?
IMRX (Immuneering Corp) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IMRX or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IMRX or GILD?
GILD has higher revenue growth at 0.0% vs -1.0% for IMRX.
Which company is more profitable: IMRX or GILD?
Immuneering Corp (IMRX) has higher gross margins at 34907.7% compared to 78.8% for GILD.
Which is the larger company: IMRX or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $174.33B compared to $368.52M for IMRX.
Should I buy IMRX or GILD in 2026?
Both IMRX and GILD have investment merit. IMRX trades at $5.41 while GILD trades at $139.77. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IMRX and GILD stock?
Key differences: Market Cap ($368.52M vs $174.33B), P/E Ratio (N/A vs 20.7x), Revenue Growth (-1.0% vs 0.0%), Gross Margin (34907.7% vs 78.8%).